Clinical Trial Update: Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial investigating efficacy of mifepristone in males with type 2 diabetes mellitus and insulin resistance; terminated with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Type 2 Diabetes Mellitus

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Charles Drew University of Medicine and Science | Conditions: Type 2 Diabetes Mellitus, Insulin Resistance | Phase 2 | Status: TERMINATED | Results posted: 2022-10-19